Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulus Appoints VP, Investor Relations And Corporate Communications

Executive Summary

Regulus Therapeutics Inc. has appointed Allison Wey vice president, investor relations and corporate communications. Wey brings over 25 years of experience in investor and media relations to the biopharma company, which specialises in medicines targeting microRNAs. She was previously vice president, investor relations at Durata Therapeutics, before which she held senior roles at Par Pharmaceuticals, Boron LePore and Associates and Edelman Financial Worldwide.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC065339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel